Cover Image
市場調查報告書

人工胰臟:開發中產品分析

Artificial Pancreas - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 334921
出版日期 內容資訊 英文 98 Pages
訂單完成後即時交付
價格
Back to Top
人工胰臟:開發中產品分析 Artificial Pancreas - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年03月11日 內容資訊: 英文 98 Pages
簡介

本報告提供目前開發中的人工胰臟的開發中產品資訊調查分析,提供您主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等相關的系統性資訊。

第1章 目錄

第2章 簡介

  • 人工胰臟概要

第3章 開發中的產品

  • 人工胰臟 - 開發中產品:各開發階段
  • 人工胰臟 - 開發中產品:各地區
  • 人工胰臟 - 開發中產品:各法規途徑
  • 人工胰臟 - 開發中產品:各核準時期 (預定)
  • 人工胰臟 - 進行中的臨床實驗

第4章 人工胰臟:正在開發的開發中產品 (各企業)

  • 人工胰臟企業 - 開發中產品:各開發階段
  • 人工胰臟 - 開發中產品:各開發階段

第5章 人工胰臟企業與產品概要

  • Advanced Biosensors-Ohio, Llc
  • Animas Corporation
  • Beta-O2 Technologies Ltd.
  • Bigfoot Biomedical, Inc.
  • BioTex, Inc.
  • Boston University
  • Cerco Medical
  • Converge Biotech, Inc.
  • Covalor Medical, LLC
  • De Montfort University
  • Defymed
  • Diabeloop
  • Dose Safety Inc.
  • Imperial College London
  • Inreda Diabetic BV
  • Kencak LLC
  • Medtronic plc
  • Miromatrix Medical Inc.
  • Pacific Diabetes Technologies, Inc.
  • Pancreum, LLC
  • PharmaCyte Biotech, Inc.
  • Rensselaer Polytechnic Institute
  • Schneider Children's Medical Center of Israel
  • TecMed, Inc.
  • The University of Newcastle
  • Ultradian Diagnostics LLC
  • Universidad Autonoma de Madrid
  • Universitat Politecnica de Valencia
  • University of California, San Francisco
  • University of California, Santa Barbara
  • University of Cambridge
  • University of Florida
  • University of Virginia
  • ViaCyte, Inc.
  • XERIS Pharmaceuticals, Inc.

第6章 人工胰臟:最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0156EPD

GlobalData's Medical Devices sector report, "Artificial Pancreas - Medical Devices Pipeline Assessment, 2016" provides an overview of Artificial Pancreas currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Pancreas pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Artificial Pancreas under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Artificial Pancreas under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Artificial Pancreas Overview

3. Products under Development

  • 3.1. Artificial Pancreas - Pipeline Products by Stage of Development
  • 3.2. Artificial Pancreas - Pipeline Products by Territory
  • 3.3. Artificial Pancreas - Pipeline Products by Regulatory Path
  • 3.4. Artificial Pancreas - Pipeline Products by Estimated Approval Date
  • 3.5. Artificial Pancreas - Ongoing Clinical Trials

4. Artificial Pancreas - Pipeline Products under Development by Companies

  • 4.1. Artificial Pancreas Companies - Pipeline Products by Stage of Development
  • 4.2. Artificial Pancreas - Pipeline Products by Stage of Development

5. Artificial Pancreas Companies and Product Overview

  • 5.1. Admetsys Corporation Company Overview
    • 5.1.1. Admetsys Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Advanced Biosensors-Ohio, Llc Company Overview
    • 5.2.1. Advanced Biosensors-Ohio, Llc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Animas Corporation Company Overview
    • 5.3.1. Animas Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Beta-O2 Technologies Ltd. Company Overview
    • 5.4.1. Beta-O2 Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Bigfoot Biomedical, Inc. Company Overview
    • 5.5.1. Bigfoot Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. BioTex, Inc. Company Overview
    • 5.6.1. BioTex, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Boston University Company Overview
    • 5.7.1. Boston University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Cerco Medical LLC Company Overview
    • 5.8.1. Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Converge Biotech, Inc. Company Overview
    • 5.9.1. Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Covalor Medical, LLC Company Overview
    • 5.10.1. Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. De Montfort University Company Overview
    • 5.11.1. De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Debiotech S.A. Company Overview
    • 5.12.1. Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Defymed, Inc. Company Overview
    • 5.13.1. Defymed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Diabeloop Company Overview
    • 5.14.1. Diabeloop Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Giner, Inc. Company Overview
    • 5.15.1. Giner, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Imperial College London Company Overview
    • 5.16.1. Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Inreda Diabetic BV Company Overview
    • 5.17.1. Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Kencak LLC Company Overview
    • 5.18.1. Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Medtronic plc Company Overview
    • 5.19.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Miromatrix Medical Inc. Company Overview
    • 5.20.1. Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Pacific Diabetes Technologies, Inc. Company Overview
    • 5.21.1. Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Pancreum, LLC Company Overview
    • 5.22.1. Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. PharmaCyte Biotech, Inc. Company Overview
    • 5.23.1. PharmaCyte Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Rensselaer Polytechnic Institute Company Overview
    • 5.24.1. Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Schneider Children's Medical Center of Israel Company Overview
    • 5.25.1. Schneider Children's Medical Center of Israel Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. TecMed, Inc. Company Overview
    • 5.26.1. TecMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. The University of Newcastle Company Overview
    • 5.27.1. The University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. TypeZero Technologies LLC Company Overview
    • 5.28.1. TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Ultradian Diagnostics LLC Company Overview
    • 5.29.1. Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Universidad Autonoma de Madrid Company Overview
    • 5.30.1. Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Universitat Politecnica de Valencia Company Overview
    • 5.31.1. Universitat Politecnica de Valencia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. University of California, San Francisco Company Overview
    • 5.32.1. University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. University of California, Santa Barbara Company Overview
    • 5.33.1. University of California, Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. University of Cambridge Company Overview
    • 5.34.1. University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. University of Florida Company Overview
    • 5.35.1. University of Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. XERIS Pharmaceuticals, Inc. Company Overview
    • 5.36.1. XERIS Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Artificial Pancreas - Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Artificial Pancreas - Pipeline Products by Stage of Development
  • Table 2: Artificial Pancreas - Pipeline Products by Territory
  • Table 3: Artificial Pancreas - Pipeline Products by Regulatory Path
  • Table 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date
  • Table 5: Artificial Pancreas - Ongoing Clinical Trials
  • Table 6: Artificial Pancreas Companies - Pipeline Products by Stage of Development
  • Table 7: Artificial Pancreas - Pipeline Products by Stage of Development
  • Table 8: Admetsys Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Admetsys Smart Pancreas - Product Status
  • Table 10: Admetsys Smart Pancreas - Product Description
  • Table 11: Advanced Biosensors-Ohio, Llc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Artificial Pancreas - Product Status
  • Table 13: Artificial Pancreas - Product Description
  • Table 14: Animas Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Hypoglycemia-Hyperglycemia Minimizer System - Product Status
  • Table 16: Hypoglycemia-Hyperglycemia Minimizer System - Product Description
  • Table 17: Beta-O2 Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: ßAir Bio-artificial Pancreas - Product Status
  • Table 19: ßAir Bio-artificial Pancreas - Product Description
  • Table 20: Beta-O2 Technologies Ltd. - Ongoing Clinical Trials Overview
  • Table 21: ßAir Bio-artificial Pancreas - An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas Beta-Air in Patients with Type 1 Diabetes Mellitus
  • Table 22: Bigfoot Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Artificial Pancreas - Product Status
  • Table 24: Artificial Pancreas - Product Description
  • Table 25: BioTex, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Artificial Pancreas - Product Status
  • Table 27: Artificial Pancreas - Product Description
  • Table 28: Boston University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: iLet - Product Status
  • Table 30: iLet - Product Description
  • Table 31: Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Islet Sheet - Product Status
  • Table 33: Islet Sheet - Product Description
  • Table 34: Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Bioartificial Pancreas System - Product Status
  • Table 36: Bioartificial Pancreas System - Product Description
  • Table 37: Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Artificial Pancreas - Product Status
  • Table 39: Artificial Pancreas - Product Description
  • Table 40: De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: InSmart Artificial Pancreas - Product Status
  • Table 42: InSmart Artificial Pancreas - Product Description
  • Table 43: Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Next Generation Artificial Pancreas - Product Status
  • Table 45: Next Generation Artificial Pancreas - Product Description
  • Table 46: Defymed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: MAILPAN - Product Status
  • Table 48: MAILPAN - Product Description
  • Table 49: Diabeloop Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Diabeloop - Product Status
  • Table 51: Diabeloop - Product Description
  • Table 52: Diabeloop - Ongoing Clinical Trials Overview
  • Table 53: Diabeloop - Crossover Evaluation of Glycemic Control Provided for Three Days by the Artificial Pancreas Diabeloop Compared to Conventional Treatment by External Insulin Pump in Patients with Type 1 Diabetes in Sedentary Position, Outstanding Meals and Physical Activity: DIABELOOP WP6.2
  • Table 54: Giner, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: BAPIOS System - Product Status
  • Table 56: BAPIOS System - Product Description
  • Table 57: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: Bio-inspired Artificial Pancreas - Product Status
  • Table 59: Bio-inspired Artificial Pancreas - Product Description
  • Table 60: Imperial College London - Ongoing Clinical Trials Overview
  • Table 61: Bio-inspired Artificial Pancreas - A Multicenter Study of Outpatient Automated Blood Glucose Control With a Bihormonal Bionic Pancreas
  • Table 62: Bio-inspired Artificial Pancreas - Closed-Loop Glucagon Administration for the Automated Prevention and Treatment of Hypoglycemia
  • Table 63: Bio-inspired Artificial Pancreas - The Summer Camp Study 2: Outpatient Automated Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas in a Pediatric Population Ages 6-11 at the Clara Barton Diabetes Camps
  • Table 64: Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Bi-Hormonal Artificial Pancreas - Product Status
  • Table 66: Bi-Hormonal Artificial Pancreas - Product Description
  • Table 67: Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: BioArtificial Pancreas - Product Status
  • Table 69: BioArtificial Pancreas - Product Description
  • Table 70: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: Hybrid Closed Loop System - Product Status
  • Table 72: Hybrid Closed Loop System - Product Description
  • Table 73: MiniMed 640G System - Product Status
  • Table 74: MiniMed 640G System - Product Description
  • Table 75: Third-Generation Artificial Pancreas System - Product Status
  • Table 76: Third-Generation Artificial Pancreas System - Product Description
  • Table 77: Medtronic plc - Ongoing Clinical Trials Overview
  • Table 78: Hybrid Closed Loop System - Feasibility Study to Evaluate the Hybrid-logic Closed Loop System in Type 1 Diabetes -Single-arm, Single-center, in Clinic Study-The DREMED Trial
  • Table 79: Hybrid Closed Loop System - Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
  • Table 80: MiniMed 640G System - A Performance Evaluation of the Enlite 3 Sensor
  • Table 81: MiniMed 640G System - Prevention of Hypoglycaemia Using the Minimed 640G System
  • Table 82: MiniMed 640G System - Standardized Evaluation of Subcutaneous Glucose Monitoring Systems under Routine Environmental Conditions
  • Table 83: MiniMed 640G System - Study of Minimed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes at Risk of Severe Hypoglycemia
  • Table 84: Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 85: Miro Pancreas - Product Status
  • Table 86: Miro Pancreas - Product Description
  • Table 87: Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 88: Single Indicating electrode Sensing Catheter - Product Status
  • Table 89: Single Indicating electrode Sensing Catheter - Product Description
  • Table 90: Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 91: Genesis Artificial Pancreas - Product Status
  • Table 92: Genesis Artificial Pancreas - Product Description
  • Table 93: PharmaCyte Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 94: Bio-Artificial Pancreas - Product Status
  • Table 95: Bio-Artificial Pancreas - Product Description
  • Table 96: Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
  • Table 97: Closed-Loop Artificial Pancreas System - Product Status
  • Table 98: Closed-Loop Artificial Pancreas System - Product Description
  • Table 99: Schneider Children's Medical Center of Israel Pipeline Products & Ongoing Clinical Trials Overview
  • Table 100: MD-Logic Artificial Pancreas - Product Status
  • Table 101: MD-Logic Artificial Pancreas - Product Description
  • Table 102: Schneider Children's Medical Center of Israel - Ongoing Clinical Trials Overview
  • Table 103: MD-Logic Artificial Pancreas - Open-label, 3 Center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of 60 Hours Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy at T1D Patients at Home
  • Table 104: TecMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 105: TecMed Artificial Pancreas - Product Status
  • Table 106: TecMed Artificial Pancreas - Product Description
  • Table 107: The University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
  • Table 108: Closed Glucose-Sensing Insulin-Delivery System - Product Status
  • Table 109: Closed Glucose-Sensing Insulin-Delivery System - Product Description
  • Table 110: TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 111: inControl AP - Product Status
  • Table 112: inControl AP - Product Description
  • Table 113: TypeZero Technologies LLC - Ongoing Clinical Trials Overview
  • Table 114: inControl AP - A Trial on Artificial Pancreas to Manage Type 1 diabetes By Automatically Regulating Insulin and Blood Sugar Levels
  • Table 115: inControl AP - Examination of New Control Algorithm of inControl AP
  • Table 116: inControl AP - International Diabetes Closed Loop Trial ("IDCL")
  • Table 117: Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 118: Artificial Pancreas - Product Status
  • Table 119: Artificial Pancreas - Product Description
  • Table 120: Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
  • Table 121: Predictive Rule-Based Algorithm - Product Status
  • Table 122: Predictive Rule-Based Algorithm - Product Description
  • Table 123: Universitat Politecnica de Valencia Pipeline Products & Ongoing Clinical Trials Overview
  • Table 124: ClosedLoop 4Meal Control - Product Status
  • Table 125: ClosedLoop 4Meal Control - Product Description
  • Table 126: University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview
  • Table 127: Bioartificial Pancreas - Product Status
  • Table 128: Bioartificial Pancreas - Product Description
  • Table 129: University of California, Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
  • Table 130: Closed-Loop Artificial Pancreas - Product Status
  • Table 131: Closed-Loop Artificial Pancreas - Product Description
  • Table 132: Pediatric Artificial Pancreas - Product Status
  • Table 133: Pediatric Artificial Pancreas - Product Description
  • Table 134: University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
  • Table 135: Florence D2A System - Product Status
  • Table 136: Florence D2A System - Product Description
  • Table 137: University of Florida Pipeline Products & Ongoing Clinical Trials Overview
  • Table 138: Bioartificial Pancreas - Type 1 Diabetes - Product Status
  • Table 139: Bioartificial Pancreas - Type 1 Diabetes - Product Description
  • Table 140: XERIS Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 141: G-Pump - BP - Product Status
  • Table 142: G-Pump - BP - Product Description
  • Table 143: Glossary

List of Figures

  • Figure 1: Artificial Pancreas - Pipeline Products by Stage of Development
  • Figure 2: Artificial Pancreas - Pipeline Products by Territory
  • Figure 3: Artificial Pancreas - Pipeline Products by Regulatory Path
  • Figure 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date
  • Figure 5: Artificial Pancreas - Ongoing Clinical Trials
Back to Top